Standard of Excellence: Speed vs. Quality in Customer Service
Knocking Down the Bone Pile: Revamp Your Components with BGA Reballing
Global Sourcing Spotlight: Balancing Speed and Flexibility Without Sacrificing Control
Quasar Medical to Acquire Nordson MEDICAL Design and Development business in Galway, Ireland and Tecate, Mexico
June 2, 2025 | Quasar MedicalEstimated reading time: 2 minutes
Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar’s global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering end-to-end solutions from initial design to large-scale production. The deal is expected to close in the third quarter of calendar 2025.
The Galway and Tecate facilities will be integrated into Quasar’s expanding global platform, adding specialized expertise in complex balloon and catheter design, rapid prototyping, and cost-efficient device near-shore assembly. Both sites provide Quasar with not only advanced know-how and IP-generating capabilities but will also add FDA-registered and ISO-certified facilities and a highly skilled workforce located in two strategic MedTech hubs.
“This is more than a bolt-on acquisition—it marks the next chapter for Quasar,” said Alex Wallstein, CEO of Quasar Medical. “We are now positioned to deliver fully integrated interventional solutions from concept to scale-up finished device, adding significant capacity in Ireland and Mexico to our well-established Asian footprint—diversifying Quasar into a global CDMO partner.”
Dave Zgonc, Vice President of Nordson MEDICAL Interventional Solutions, said, “We’re extremely proud of the highly skilled teams in Galway and Tecate, their expertise, and the customer partnerships they’ve built over the years in our finished device contract manufacturing business. We are thankful for their commitment and dedication to this business.”
Expanded Capabilities, Global Reach
With this acquisition, Quasar Medical now operates 10 facilities across North America, Europe, Israel, and Asia, providing added expertise in design, development, balloon catheter systems, micro-EM sensors, and rapid scale-up of low-cost assembly and manufacturing.
- 800,000 square feet of manufacturing space
- Over 4,200 employees, including over 50 NPD Engineers
- FDA-registered and ISO 13485 certified
- Galway: design, prototyping, and product development, as well as manufacturing
- Tecate: cost-effective, scalable device manufacturing and assembly
Customer Benefits & Strategic Impact
Quasar Medical’s customers will benefit from:
- Integrated design-for-manufacturing and scalable production
- Seamless program transfers and faster market readiness
- Near-shore operations for US customers
- Regionally optimized manufacturing strategies balancing speed, quality, and cost
- Robust quality infrastructure with FDA and ISO 13485 compliance across all facilities
This strategic step expands Quasar’s ability to support global OEMs and innovators with speed, flexibility, innovation, and precision—from concept to prototype to finished device delivery.
Quasar will work closely with Nordson to ensure a smooth transition for all customers and suppliers. Upon closing, the Galway and Tecate sites will be fully integrated into the Quasar platform.
Share on:
Testimonial
"Our marketing partnership with I-Connect007 is already delivering. Just a day after our press release went live, we received a direct inquiry about our updated products!"
Rachael Temple - AlltematedSuggested Items
Henger Microelectronics Expands Global Footprint with Major Equipment Shipment to Southeast Asia
10/31/2025 |Henger Microelectronics has reached a major milestone in its global expansion strategy with the successful shipment of advanced plasma etching and cleaning systems, along with automation equipment, to multiple countries and regions across Southeast Asia. This achievement marks a significant step forward in the company’s international growth and reinforces its position as a leading force in the global plasma equipment industry.
PCBAA Names Industry Veteran Dan Weber to Board of Directors
10/31/2025 | PCBAAThe Printed Circuit Board Association of America has added Dan Weber, Executive Vice President and General Counsel at TTM Technologies, to the PCBAA board of directors.
KLA Reports Fiscal Q1 2026 Results
10/31/2025 | PRNewswireKLA Corporation announced financial and operating results for its first quarter of fiscal year 2026, which ended on Sept. 30, 2025, and reported GAAP net income of $1.12 billion and GAAP net income per diluted share of $8.47 on revenues of $3.21 billion.
Samsung Teams With NVIDIA to Lead the Transformation of Global Intelligent Manufacturing Through New AI Megafactory
10/31/2025 | SamsungSamsung Electronics today announced plans to create a new AI Megafactory in collaboration with NVIDIA, marking a major milestone in the company’s efforts to lead the global paradigm shift toward AI-driven manufacturing.
Fresh PCB Concepts: Resilience and Renewal in Domestic PCB Manufacturing
10/30/2025 | Team NCAB -- Column: Fresh PCB ConceptsAs veterans of PCB manufacturing, we have spent much of our careers walking factory floors, examining copper circuits under microscopes, and troubleshooting plating lines when they go awry at 2 a.m. We can say with confidence that PCBs are the unsung heroes of modern life. They’re in everything, from toothbrushes and thermostats to satellites and defense systems.